AUSTIN, Texas–(BUSINESS WIRE)–Babson Diagnostics, a transformative medical technology company improving customer access to diagnostic blood testing, today announced the closing of $31 million in an oversubscribed Series B funding round, led by Emerald Development Managers, with full participation by existing investors Siemens Healthineers, Prism Ventures, and Lago Consulting Group. The Series B fundraise will accelerate the commercialization of Babson’s disruptive technology that will make ro